Qualigen Therapeutics Appoints Amy Broidrick to its Board of Directors

CARLSBAD, Calif., Aug. 28, 2020 -- (Healthcare Sales & Marketing Network) -- Qualigen Therapeutics, Inc. (Nasdaq: QLGN) announced today the addition of pharmaceutical executive Amy Broidrick to the company's Board of Directors. Ms. Broidrick's background... Biopharmaceuticals, Oncology, Personnel Qualigen Therapeutics
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news